Leptin can regulate several immune functions. However, the role of leptin on lymphocyte function has not been recognized in vivo. Accordingly, we have investigated the effect of leptin on starvation-induced immune dysfunction using diet-induced obese mice. To induce obesity, C57BL/6J mice were fed a high-fat diet for 14 weeks and control mice were fed a standard diet for the same period. The obese and control groups of mice were then starved for 48 h, and received intraperitoneal injections of recombinant leptin or phosphate-buffered saline four times during starvation. Other control mice in both diet groups were free fed without being starved. Although starvation of the control mice dramatically reduced the weights of the immune organs, cytokine production and increased proliferation of cultured splenocytes, these levels returned to those of the free-feeding groups with exogenous leptin administration. However, these effects of leptin were not observed in obese mice. These findings provide some evidence that leptin can regulate the immune function in vivo. It is also suggested that the action of leptin might not appear in obesity.
Introduction
It is known that the major role of leptin, adipocyte-derived hormone, is the regulation of appetite and energy expenditure through the hypothalamus (Campfield et al. 1995 . Recent studies have reported that leptin receptors are found not only in the hypothalamus but also in many peripheral organs (Hoggard et al. 1997 , Lord et al. 1998 ). This suggests other functional roles of leptin in peripheral organs, including the immune system. Several in vitro studies have shown that leptin can up-regulate the immune function, such as proliferation and cytokine production of lymphocytes, or phagocytic function, etc. (Loffreda et al. 1998 , Romero et al. 2000 . Recent in vivo studies have also demonstrated that leptin protects mice from a decrease in the weights of the thymus and spleen and a reduction in the number of lymphocytes induced by starvation (Howard et al. 1999) . It is therefore suggested that the serum leptin level may relate to immune function. As leptin is significantly correlated with body fat mass, leptin concentrations in sera could be changed in malnutrition, anorexia nervosa or obesity, which are associated with abnormal body weight (Considine et al. 1996) . Decreased immune function occurs in many diseases, including infection (Keusch 2003) . Accordingly, it is very important to clarify the relationship between leptin and immune function. However, the in vivo effects of leptin on lymphocyte function have not been fully investigated. Furthermore, the action of leptin on immunity in subjects with abnormal body weights is not yet understood. Obese subjects often show high serum leptin levels compared with subjects with normal body weight (Considine et al. 1996) . Although most human obese subjects do not have a deficiency of leptin or its receptor, the action of leptin through the hypothalamus does not appear properly in them. The cause of leptin resistance in obesity is not fully understood, although lesion of the defective leptin pathway from peripheral to central has been suggested ( Van-Heek et al. 1997) . We have previously reported in an in vitro study that cytokine profile and leptin sensitivity in cytokine production by splenocytes was changed in diet-induced obese mice, a good model for human obesity (Mito et al. 2000 (Mito et al. , 2002 . It is therefore speculated that the action of leptin in peripheral tissue may also be changed by obesity. In the present study, we have investigated the role of leptin on lymphocyte function in vivo, and the effect of leptin on obesity. Diet-induced obese mice and control mice were treated with leptin during starvation. This may be a good model to identify the effects ofleptin on immune function by its replacement, because starvation induces a significant reduction in serum leptin concentrations and in several immune functions.
Materials and Methods

Animals and diet
Female C57BL/6J mice were obtained from Sankyo Laboratories (Tokyo, Japan) at 4 weeks of age. They were housed four per cage in a temperature-controlled room with a 12 h light:12 h darkness cycle. Obesity was induced in one group (24 mice) by a high-fat diet supplemented with lard (obese group). Another group of mice was given a standard diet as a control (control group). On a caloric basis, the high-fat diet consisted of 10·8% protein, 38·9% carbohydrate and 50·3% fat, whereas the standard diet consisted of 16·1% protein, 73·6% carbohydrate and 10·3% fat. The composition of the diets is shown in Table 1 . Mice were allowed free access to water and either diet for 14 weeks. Diets were based on AIN 93M (Oriental Yeast, Tokyo, Japan). For the period of the study body weight and food consumption of all the mice were measured once a week.
Starvation protocol
The protocol for starvation and leptin administration was based on a previous report (Lord et al. 1998) . After all the mice had been maintained on their allotted diets for 14 weeks, the obese and control groups were divided into three groups each. Two groups of mice from both the obese and control groups were deprived of food for 48 h, and received i.p. injections of either 0·2 ml recombinant murine leptin (1 µg/g; R&D Systems, Inc., Minneapolis, MN, USA, initial body weight in phosphate-buffered saline (PBS)) or PBS at 0900 and 1800 h. Another group of mice from both groups was allowed ad libitum access to high-fat or standard allotted diet and received i.p. injection of 0·2 ml PBS. Mice were killed by cervical dislocation 15 h after the last injection of leptin or PBS.
Leptin measurement
Blood was drawn and serum was obtained by centrifugation. It was stored at 30 C until analysis. The enzymelinked immunosorbent assay (ELISA) for serum leptin concentrations was conducted using antibody pairs and recombinant mouse leptin (R&D Systems, Inc), according to the manufacturer's instructions.
Preparation and culture of splenocytes (spleen lymphocytes)
Spleens were aseptically removed and placed in RPMI 1640 medium (NISSUI, Tokyo, Japan). Single cell suspensions were made by teasing spleens apart with a stainless steel mesh and filtering through a 200 µm nylon mesh. Cell suspensions were collected in sterile conical tubes and washed three times in RPMI 1640 medium containing 5% heat-inactivated fetal calf serum (JRH, Lenaxa, Australia), -glutamine (2 mM; GIBCO, Grand Island, NY, USA), penicillin (100 U/ml; GIBCO) and streptomycin (100 µg/ml; GIBCO), followed by centrifugation at 1200 r.p.m. for 10 min at 4 C. Cells were counted using a haemocytometer and diluted in medium to a density of 4 10 6 cells/ml. Splenocytes were cultured in the presence of anti-CD3´antibody (1 µg/ml; CL7202: Cedarlane, Hornby, Ontario, Canada), phytohaemagglutinin (PHA; 2 µg/ml; DIFCO, Detroit, MI, USA) or lipopolysaccharide (10 µg/ml; Sigma, St Louis, MO, USA) for 48 h, or 72 h at 37 C in a 5% CO 2 atmosphere.
Proliferative response of splenocytes
After 72 h of culture the proliferative response of the splenocytes was measured by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Following the addition of MTT solution (200 µg/ml), the cells were incubated for 3 h at 37 C. The MTTformazon product formation was dissolved by the addition of 10% SDS in 0·01 M HCl. The optical density (O.D.) of each well was measured using test and reference wavelengths of 550 nm and 650 nm.
Interleukin (IL)-2, interferon (IFN)-and IL-4 production
To measure cytokine production, ELISAs were performed on culture supernatants obtained from anti-CD3´antibody or PHA-stimulated splenocytes. Supernatants were collected after incubation for 48 h, centrifuged and stored at 30 C until analysis. Mousematched antibody pairs (IL-2) and ELISA mini kits (IFN-and IL-4; Endogen, Cambridge, MA, USA) were used for this assay. The optimal incubation time of the splenocytes for cytokine production was decided before the assay.
Statistical analysis
Data are shown as the means S.E. Statistical comparisons on the three groups in each diet were made by ANOVA including all possible two-way interactions, and were compared with the others by Fisher's protected leastsignificant difference test. The data for starvation plus PBS, leptin or free feeding in the control group were compaired with those in the obese group using unpaired Student's t-test.
Results
Body weight
The obese group showed a marked increase in final body weight compared with the control group of mice (Table  2) . Starvation for 48 h significantly reduced body weight in both obese and control mice. Treatment with leptin during the period of starvation did not affect body weight in either group.
Leptin concentrations in sera
Leptin concentrations in sera were higher in all obese groups than in the control group (Table 3) . Although serum leptin levels were decreased in starved mice given the PBS injection compared with the free-feeding mice, they were slightly increased by the leptin treatment in both the obese and control groups.
Spleen weight, thymus weight and liver weight
Spleen weight was significantly decreased by starvation (Fig. 1) . However, leptin treatment restored it in both diet groups: obese group (free feeding 97 3 mg, starvation-PBS 80 4 mg, starvation-leptin 88 3 mg) and control group (free feeding 92 5 mg, starvation-PBS 47 3 mg, starvation-leptin 62 6 mg).
In the control mice, leptin treatment slightly protected starvation-induced thymus atrophy (free feeding 48 3 mg, starvation-PBS 30 3 mg, starvation-leptin 34 6 mg) (Fig. 2) . However, these phenomena were not observed in the obese group (free feeding 62 4 mg, starvation-PBS 56 5 mg, starvation-leptin 52 3 mg).
Starvation and leptin did not affect liver weight in the control and obese groups (data not shown).
Proliferative response of splenocytes
Although starvation caused an increase in the proliferative response of splenocytes in control mice, it was downregulated by leptin to the level of the free-feeding group (free feeding 0·411 0·03 O.D., starvation-PBS 
Cytokine production by splenocytes
In control mice, starvation caused a significant reduction in IFN-production stimulated by anti-CD3 antibody compared with the free-feeding group; nevertheless, mice treated with leptin during the period of starvation were completely protected ( Fig. 4A ) (control group: free feeding 48 038 873 pg/ml, starvation-PBS 36 699 2193 pg/ ml, starvation-leptin 48 056 2459 pg/ml). A similar tendency was found in IFN-production with PHA stimulation (Fig. 4B ) (control group: free feeding 5840 897 pg/ml, starvation-PBS 3396 612 pg/ml, starvation-leptin 5219 416 pg/ml). On the other hand, these effects of starvation or leptin administration were not found in the obese group stimulated with anti-CD3 (obese group: free feeding 46 197 1669 pg/ml, starvation-PBS 45 921 4624 pg/ ml, starvation-leptin 47 034 1734 pg/ml) or with PHA (obese group: free feeding 7266 1072 pg/ml, starvation-PBS 7588 1566 pg/ml, starvation-leptin 8151 725 pg/ml). IL-2 production stimulated by PHA in obese and control mice presented with the same pattern as IFN- (Fig. 5 ) (obese group: free feeding 1270 78 pg/ ml, starvation-PBS 1248 61 pg/ml, starvation-leptin 1316 74 pg/ml; control group: free feeding 1436 84 pg/ml, starvation-PBS 1149 53 pg/ml, starvationleptin 1185 66 pg/ml). However, neither IL-2 nor IL-4 production with anti-CD3 stimulation was altered by starvation or leptin administration (data not shown).
Discussion
Previous studies have reported that starvation or malnutrition induces immune dysfunction (Chandra 1980 , Wing et al. 1988 , Faggioni et al. 2001 . Leptin has recently been reported to have a protective role. Furthermore, it has also been reported that leptin can up-regulate immune function in vitro (Loffreda et al. 1998 , Lord et al. 1998 , Romero et al. 2000 . However, the role of leptin in lymphocyte function in vivo has not been fully elucidated and furthermore the in vivo effect of leptin on obesity has never been investigated. Accordingly, we investigated the effect of leptin administration on starvation-induced immune dysfunction using dietinduced obese and normal weight mice. In this study, body weight and serum leptin concentrations were much higher in mice fed a high-fat diet (obese group) than in mice fed a standard diet (control group). Starvation induced the significant reduction of body weight in diet-induced obese and control mice. Although the serum leptin level was also decreased by starvation, exogenous recombinant leptin administration during the period of starvation was partly reflected in the serum level in both groups, because of the very rapid metabolic rate of leptin (Ahren et al. 2000) . Starvation and leptin administration did not affect liver weight in obese and control groups. However, a different tendency was observed in immune organs, such as the spleen and the thymus. Although starvation caused a significant reduction in these immune organ weights in the control group, the administration of leptin could protect against it. This effect was less dramatic in the thymus compared with the spleen which might reflect the different sensitivity of T cells and B cells to leptin. These in vivo findings were basically consistent with a previous report (Howard et al. 1999) . However, the effect of leptin on lymphocyte function in vivo has not yet been fully investigated. Previous in vivo studies were limited to disease animal models or genetically obese animals, and cytokine profiles were not investigated , Busso et al. 2002 , Siegmund et al. 2002 . These studies reported that leptin affected the host in disease conditions. Further, a recent human study has shown that leptin administration improved T-cell hypo-responsiveness in obese children with a genetic mutation of the leptin gene (Farooqi et al. 2002) . The in vivo effect of leptin has not been investigated either in humans or other animals in normal conditions except for the response to delayed-type hypersensitivity (DTH) (Lord et al. 1998) . Accordingly, the analysis of the in vivo role of leptin on immunity using normal mice will be important to clarify the relationship of leptin and many diseases with immune dysfunction. In previous in vitro studies using human and other animal lymphocytes, leptin induced Th1 predominance in the immune system (Lord et al. 1998 , Romero et al. 2000 , Faggioni et al. 2001 . In the present study, we found that not only in vitro but also in vivo leptin affected immune organ weights, proliferative response and cytokine production by lymphocytes. Furthermore, IFN-, a Th1 type of cytokine, production by splenocytes was significantly decreased in mice which were not treated with leptin during starvation, although its level in mice treated with leptin during starvation was maintained at the same level as free-feeding mice. Similar results were observed for IL-2 and IL-4 production stimulated with PHA (data not shown). Furthermore, we have additionally investigated the effect of leptin on cytokine production in free-feeding mice treated with leptin or PBS using the same starvation protocol as this study (data not shown). We were able to confirm the established role of leptin which suppresses the appetite and decreases body weight. In addition, IFN-and IL-2 production by splenocytes stimulated with anti-CD3 antibody in free-feeding mice treated with leptin was significantly increased compared with mice treated with PBS. Accordingly, these results indicated that leptin replacement in normal mice may compensate for these cytokine reductions in starvation. Cytokine-secreting immune cells have an important role in the immune system, because changes in its profile are correlated with many diseases (Abbas et al. 1996) . Decreased Th1 cytokine triggers infection (Fidel 2002) . It might therefore suggest that a crisis of infection or a fall in immune function during malnutrition is, at least in part, associated with decreased serum leptin levels. On the other hand, recent studies have reported how leptin accelerates autoimmune disease by Th1 cytokine predominance (Busso et al. 2002 . Increased Th1 cytokines, IFN-and IL-2, are correlated with the pathophysiology of autoimmune diseases (Skurkovich et al. 2002) . Therefore, our in vivo results may provide important data on immunity during abnormal serum leptin conditions.
Obesity causes abnormal leptin levels in sera because of significantly increased adipose tissue (Frederich et al. 1995 . However, the major role of leptin through the hypothalamus, regulation of appetite and energy expenditure, does not properly appear during obesity. The cause of this has not been elucidated, and the effect of leptin on peripheral tissue, including the immune system, has not yet been investigated in obesity. In the present study, we have indicated that the effects of leptin on immunity in the obese group were different from those in the control group.
Although starvation induced a decrease in spleen weight in obese mice, leptin administration during starvation protected it. However, cytokine (IFN-, IL-2 and IL-4) production by splenocytes in obese mice was not affected by leptin administration. Leptin receptor (its form is similar to that of the cytokine receptor family gp 130) is expressed in various immune cells (Hoggard et al. 1997 , Baumann et al. 1996 , Lord et al. 1998 . Abnormalities in signal transduction through the leptin receptor in lymphocytes from obese subjects have not been investigated. On the other hand, the smaller effect of leptin on immune cells in the obese group might be explained by the fact that changes of leptin concentration by starvation or leptin replacement are smaller in obesity than in the control group. We have found that treatment with leptin in normal mice activated the production of the Th1 type cytokine in vivo by an additional study (data not shown). Accordingly, it is possible that diet-induced obese mice had leptin resistance immunity in advance because several immune functions were decreased in obesity in spite of high concentrations of serum leptin. Although this mechanism is not clear at present, cytokine suppression signalling (SOCS-3) may be one of the candidates. This protein is part of a family of cytokine signalling which inhibits JAK activity and relates to the pathogenesis of many inflammatory diseases (Alexander 2002) . Leptin induces SOCS-3 expression in the hypothalamus (Bjørbaek et al. 1998) , while SOCS-3 suppresses leptin signalling by inhibition of tyrosine phosphorylation of JAK2 in the leptin receptor (Bjørbaek et al. 1999) . It has also been reported that SOCS-3 mRNA is expressed in immune cells (Seki et al. 2003) . Accordingly, it is possible that an abnormal serum leptin condition like obesity may increase leptin resistance not only in the hypothalamus but also in many other tissues through SOCS-3. It is necessary to clarify the signal transduction of leptin on immune cells in obesity by further studies.
The findings in this study present the first in vivo evidence that supports the important role of leptin in lymphocyte function, and suggests dysfunction of its system in obesity.
